Description

• Title:
  Molecular markers of VEGF, TNF-α and TNF-β IN bladder cancer patients at stage T3N0M0 and their relationship with the degree of tumor neoplasia
• Creator:
  Fedevych, O.;
  Fedevych, V.;
  Pasichnyk, S.
• Description:
  17 bladder cancer patients, stage T3N0M0 (main group), were included in the study. There were 10 men (mean age 58.2 ± 6.2 years) and 7 women (mean age 59.5 ± 2.4 years). Clinical data of 12 healthy individuals were used as a control. According to statistic data, the average level of VEGF in bladder cancer patients urine was 246.55± 6.90 pg/ml which significantly exceeded this indicator in the control group (129.21± 7.60 pg/ml), the difference was statistically significant At bladder cancer diagnosis the sensitivity and specificity of the urinary level of TNF-α was low and amounted to 30% and 20%, respectively, and the level of TNF-β was even lower - 25% and 20%, respectively, which is not representative for the pathology under study.
• Object availability:
  free access
• Rights: https://creativecommons.org/licenses/by-nc-sa/4.0 ;
  Prawa autorskie (c) 2023 O. Fedevych, V. Fedevych, S. Pasichnyk
• Date:
  2023.04.28
• Type:
  info:eu-repo/semantics/article;
  info:eu-repo/semantics/publishedVersion
• Language:
  English
• Source:
  Journal of Education, Health and Sport; Vol. 13 No. 4 (2023); 379-385;
  Journal of Education, Health and Sport; Tom 13 Nr 4 (2023); 379-385;
  2391-8306
• Format:
  application/pdf
• Publisher:
  Nicolaus Copernicus University, Toruń, Poland
• Relation: https://apcz.umk.pl/JEHS/article/view/45806/36299
• Subject:
  carcinoma;
  urinary bladder;
  genotype;
  growth factor;
  necrosis factor;
  polymorphism;
  differentiation
• Identifier: https://apcz.umk.pl/JEHS/article/view/45806
• Data provider:
  Akademicka Platforma Czasopism
• Can I use it?:
  seek permission
• Type:
  text